Hong Kong Stock Movement | GenFleet Therapeutics-B (02595.HK) rises over 6% again; GFH375 has entered two single-agent registrational Phase III trials for previously treated KRAS G12D
Zhitong Finance APP has learned that GenFleet Therapeutics-B (02595.HK) rose more than 6% again. As of press time, it was up 5.03% at HK$29.26, with a turnover of HK$79.4175 million.
Latest
